Cosmo Pharmaceuticals N.V. logo

Cosmo Pharmaceuticals N.V. (COPN)

Market Closed
19 Jun, 15:20
SIX SIX
68. 50
CHF
+2
+3.0075%
CHF
1B Market Cap
104.48 P/E Ratio
8% Div Yield
110,329 Volume
0 Eps
66.5 CHF
Previous Close
Add Transaction
Day Range
66.6 69.9
Year Range
53.4 129.4
Want to track COPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
9 Mar 2026
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
23 Jul 2025
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
23 May 2025
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
24 Jul 2024
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
24 May 2024
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
20 Mar 2024
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
29 Jul 2016
0.1
0.42
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
23 Mar 2016
-
0.43
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
30 Jul 2015
-
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
25 Mar 2015
1.1
-
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
30 Jul 2014
0.1
5.5
Cosmo Pharmaceuticals N.V. logo
COPN Cosmo Pharmaceuticals N.V.
27 Mar 2014
0.5
0.46

COPN Earnings Reports FAQ

What is the earnings per share (EPS) for COPN?

The current EPS is 0.

What is the company's earnings growth rate?

Over the past 11 years, the earnings growth rate has been approximately -4.45%, reflecting the COPN's performance and SIX market conditions.

When is the next earnings release date?

Cosmo Pharmaceuticals N.V has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Cosmo Pharmaceuticals N.V are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for COPN at this time, as Cosmo Pharmaceuticals N.V has no recent EPS data to calculate it.